Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
Experimental Hematology
|
January 1, 1995
Ultrastructural localization of stem cell factor in canine marrow-derived stromal cells
R Huss, D S Hong, C Beckham, et al.
Blood
|
November 1, 1995
Major histocompatibility complex class II-mediated inhibition of hematopoiesis in long-term marrow cultures involves apoptosis and is prevented by c-kit ligand
D S Hong, C Beckham, R Huss, et al.
Scientific Reports
|
February 12, 2014
Evolution of conduction channel and its effect on resistance switching for Au-WO₃-x-Au devices
D S Hong, Y S Chen, Ying Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 11, 2011
Phase I study of the effects of renal impairment on the pharmacokinetics and safety of satraplatin in patients with refractory solid tumors
M D Galsky, L H Camacho, E G Chiorean, et al.
Genes, Brain, and Behavior
|
December 7, 2013
Brain morphology in children with 47, XYY syndrome: a voxel- and surface-based morphometric study
J-F Lepage, D S Hong, M Raman, et al.
Annals of Hematology
|
March 1, 1997
In vivo radioprotective effect of AcSDKP on canine myelopoiesis
H J Deeg, K Seidel, D S Hong, et al.
The Korean Journal of Internal Medicine
|
January 1, 1997
A case of coagulation factor V deficiency complicated with intracranial hemorrhage
S G Yoon, S T Cho, S K Park, et al.
Transplantation
|
November 7, 1999
Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis
M Yamaguchi, P A McSweeney, L Kimball, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2015
A phase 1 study of intermittently administered pazopanib in combination with continuous daily dosing of lapatinib in patients with solid tumors
H Henary, G C George, J Wheler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2012
Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience
J J Wheler, A M Tsimberidou, D S Hong, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
Experimental Hematology
|
January 1, 1995
Ultrastructural localization of stem cell factor in canine marrow-derived stromal cells
R Huss, D S Hong, C Beckham, et al.
Blood
|
November 1, 1995
Major histocompatibility complex class II-mediated inhibition of hematopoiesis in long-term marrow cultures involves apoptosis and is prevented by c-kit ligand
D S Hong, C Beckham, R Huss, et al.
Scientific Reports
|
February 12, 2014
Evolution of conduction channel and its effect on resistance switching for Au-WO₃-x-Au devices
D S Hong, Y S Chen, Ying Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 11, 2011
Phase I study of the effects of renal impairment on the pharmacokinetics and safety of satraplatin in patients with refractory solid tumors
M D Galsky, L H Camacho, E G Chiorean, et al.
Genes, Brain, and Behavior
|
December 7, 2013
Brain morphology in children with 47, XYY syndrome: a voxel- and surface-based morphometric study
J-F Lepage, D S Hong, M Raman, et al.
Annals of Hematology
|
March 1, 1997
In vivo radioprotective effect of AcSDKP on canine myelopoiesis
H J Deeg, K Seidel, D S Hong, et al.
The Korean Journal of Internal Medicine
|
January 1, 1997
A case of coagulation factor V deficiency complicated with intracranial hemorrhage
S G Yoon, S T Cho, S K Park, et al.
Transplantation
|
November 7, 1999
Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis
M Yamaguchi, P A McSweeney, L Kimball, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2015
A phase 1 study of intermittently administered pazopanib in combination with continuous daily dosing of lapatinib in patients with solid tumors
H Henary, G C George, J Wheler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2012
Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience
J J Wheler, A M Tsimberidou, D S Hong, et al.
Page
of 5